Pancreatic Cancer Diabetes & Weight Loss Drug Lawsuits
Pancreatic Cancer Lawsuits Related to Ozempic, Wegovy, Mounjaro, Saxenda, Trulicity, and Rybelsus
The potential link between widely used weight loss and diabetes drugs, such as Ozempic, Wegovy, Mounjaro, and others, and pancreatic cancer has become a topic of increasing concern and debate in the medical community. Riddle & Brantley is actively investigating these claims and we are ready to file pancreatic cancer lawsuits related to diabetes and weight loss drugs if the situation allows.
For a FREE, no-obligation case review concerning a potential weight loss and diabetes drug lawsuit, please call 1-800-525-7111. There are no upfront costs, and we don’t get paid unless you do.
These medications, part of the glucagon-like peptide-1 (GLP-1) receptor agonists class, are increasingly popular for their effectiveness in managing Type 2 diabetes and aiding in weight loss. However, emerging research and patient reports have raised questions about their long-term safety, particularly regarding the risk of pancreatic cancer.
Pancreatic Cancer Diabetes & Weight Loss Drug Lawsuits Guide
- What Brands of Weight Loss and Diabetes Drugs May Be Linked?
- Do Weight Loss and Diabetes Drugs Cause Pancreatic Cancer?
- Pancreatic Cancer Lawsuits Against Diabetes & Weight Loss Drug Manufacturers
- Why Riddle & Brantley for Your Pancreatic Cancer Claim?
What Brands of Weight Loss and Diabetes Drugs May Be Linked?
Many different brands of weight loss and diabetes drugs may be linked to increased risk of pancreatic cancer, including:
- Ozempic
- Wegovy
- Mounjaro
- Saxenda
- Trulicity
- Rybelsus
IMPORTANT: The manufacturers of these drugs have strongly denied any liability or wrongdoing, and no settlements or verdicts have been made in these claims. Our firm is still evaluating the potential link between pancreatic cancer and these medications, and no definitive causal relationship has been established.
“These are serious allegations, and we are committed to getting justice for victims.”
–Gene Riddle, attorney
What is Pancreatic Cancer?
Pancreatic cancer involves cells in the pancreas — a vital gland behind the stomach — that multiply out of control. It’s known for its aggressive nature and poor prognosis, primarily because it’s often diagnosed at a late stage when treatment is more challenging. The pancreas plays an important role in digestion and regulating blood sugar, and cancer there can severely impact these functions. Pancreatic cancer is often life-threatening.
Symptoms of Pancreatic Cancer
According to the Cleveland Clinic, symptoms of pancreatic cancer may include:
- Jaundice (yellowing of the skin)
- Dark urine
- Light-colored stool
- Upper abdominal pain
- Middle back pain
- Fatigue
- Itchy skin
- Nausea and vomiting
- Gas or bloating
- Lack of appetite
- Blood clots
- Weight loss
- New-onset diabetes
IMPORTANT: If you’ve experienced any of the symptoms above, contact your medical provider immediately. Pancreatic cancer can be life-threatening, and early detection is key to improving treatment’s effectiveness.
Do Weight Loss and Diabetes Drugs Cause Pancreatic Cancer?
Research is ongoing, and no definitive causal relationship has been established, but evidence indicates that certain active ingredients in weight loss and diabetes drugs may increase the risk of pancreatic cancer.
Recent studies have started to explore the potential association between GLP-1 receptor agonists and an increased risk of pancreatic cancer. While these investigations are still in their early stages, the concerns stem from the role of these drugs in stimulating the pancreas. The hypothesis is that prolonged stimulation could potentially lead to abnormal cell growth and, eventually, cancer. It’s important to note that current research does not conclusively establish a direct causative link but suggests a correlation that requires further investigation.
Pancreatic Cancer Lawsuits Against Diabetes & Weight Loss Drug Manufacturers
This potential pancreatic cancer link has led to lawsuits against the manufacturers of drugs like Ozempic and Wegovy. Patients who developed pancreatic cancer after using these medications have started filing lawsuits, alleging that the manufacturers failed to provide adequate warnings about the risks associated with these drugs. These lawsuits claim negligence in various forms, including insufficient safety studies, inadequate warnings to the public and medical community, and aggressive marketing practices overshadowing the potential risks.
Claims against Ozempic, Wegovy, Mounjaro, and other drug makers are gaining momentum. This is partly due to the U.S. Food & Drug Administration’s recently increased scrutiny. In September 2023, the FDA required several manufacturers to add warning labels to certain weight loss and diabetes drugs due to potential gastrointestinal disease risks.
Do You Have a Claim?
You may have a claim for a weight loss and diabetes drug lawsuit if you meet the following criteria:
- Took prescribed Ozempic, Wegovy, Mounjaro, Saxenda, Trulicity, or Rybelsus medication
- Were diagnosed with one of the following conditions:
- Pancreatic cancer
- Pancreatitis
- Stomach paralysis (gastroparesis)
- Persistent vomiting
- Persistent nausea and diarrhea
- Stomach not working
Don’t wait — the longer you wait to contact an experienced dangerous drugs lawyer, the harder it may be to secure the compensation you need and deserve. Call Riddle & Brantley today for a FREE case review at 1-800-525-7111.
We’ll listen to you, review your unique circumstances, and advise you on your best available legal options for pursuing justice and compensation. There are no upfront costs and no attorney fees unless we win your case and you receive compensation.
Why Riddle & Brantley for Your Pancreatic Cancer Claim?
Pancreatic Cancer Diabetes & Weight Loss Drug Lawsuits Lawyer, Gene Riddlenot
Since 1985, Riddle & Brantley has fought for injury victims, securing over $725 million in compensation for our valued clients since 2000 alone (see disclaimer below).
“I was treated honestly and with respect — 5 stars and above.”
-Melvin T., Riddle & Brantley client
Our attorneys have been recognized with many prestigious awards and memberships (see disclaimer below), including:
- Multi-Million Dollar Advocates Forum
- Million Dollar Advocates Forum
- The National Trial Lawyers Top 100
- The National Trial Lawyers Top 40 Under 40
- The National Association of Distinguished Counsel
- The Litigator Award
- Super Lawyers
- Super Lawyers “Rising Stars”
- AV Preeminent Rating by Martindale-Hubbell
*** Disclaimer: The results mentioned are intended to illustrate the type of cases handled by the firm. These results do not guarantee a similar outcome, and they should not be construed to constitute a promise or guarantee of a particular result in any particular case. Every case is different, and the outcome of any case depends upon a variety of factors unique to that case.
*** Disclaimer: An attorney must meet certain requirements to join these organizations or receive these awards. For more information on Membership Criteria for Million Dollar Advocates Forum, Multi-Million Dollar Advocates Forum, Super Lawyers, Super Lawyers “Rising Star” designation, The National Trial Lawyers Top 100, The National Trial Lawyers Top 40 Under 40, The National Association of Distinguished Counsel, AV Preeminent designation by Martindale-Hubbell, the Litigator Award, and other memberships, awards, and accolades, please visit our Membership Criteria page. These awards and memberships should not be construed as a promise or guarantee of a similar result. Each case is different and must be evaluated separately.